Ibrutinib, a BTK inhibitor used for treatment of...

Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity in allergic cancer patients receiving drug

Regan, Jennifer A., Petrich, Adam M., Dispenza, Melanie C., Ma, Shuo, Gordon, Leo I., Bochner, Bruce S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
139
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2016.12.748
Date:
February, 2017
File:
PDF, 126 KB
english, 2017
Conversion to is in progress
Conversion to is failed